MedWatch

Headhunter calls outgoing Leo Pharma CEO a "flop"

It was a mistake to hire Catherine Mazzacco as CEO of Leo Pharma, says a headhunter focused on the pharmaceutical industry, who predicts that the board will look internationally to find her replacement.

Catherine Mazzacco, being interviewed in 2019 | Photo: Liselotte Sabroe/Ritzau Scanpix

After two years as CEO of Leo Pharma, Catherine Mazzacco is stepping down with immediate effect.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs